Norway Point Of Care Diagnostics Market Size & Outlook

Name: Norway Point Of Care Diagnostics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The point of care diagnostics market in Norway is expected to reach a projected revenue of US$ 126.8 million by 2033. A compound annual growth rate of 3.8% is expected of Norway point of care diagnostics market from 2026 to 2033.

Clinical Diagnostics
- Point of Care (PoC) Diagnostics
  - Point Of Care Diagnostics Market Outlook

Norway point of care diagnostics product outlook (Revenue, USD million, 2021-2033)
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
  - HIV POC
  - Clostridium Difficile POC
  - HBV POC
  - Pneumonia or Streptococcus Associated Infections
  - Respiratory Syncytial Virus (RSV) POC
  - HPV POC
  - Influenza/Flu POC
  - HCV POC
  - MRSA POC
  - TB and Drug-resistant TB POC
  - HSV POC
  - COVID-19
  - Other Infectious Diseases
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Autoimmune Diseases
- Urinalysis/Nephrology
Norway point of care diagnostics end use outlook (Revenue, USD million, 2021-2033)
- Clinics
  - Pharmacy & Retail Clinics
  - Physician Office
  - Urgent Care Clinics
  - Non-practice Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratory

Norway Point Of Care Diagnostics Market Size & Outlook

Data Tree

Sign up - it's easy, and free!